热门资讯> 正文
LENZ Therapeutics获得Ridgeback Capital 3000万美元投资
2024-07-15 20:12
- LENZ Therapeutics (NASDAQ:LENZ) said it is looking to raise $30M through a stock purchase agreement with Ridgeback Capital Investments.
- Shares in the company were up 7% in premarket trade.
- The firm intends to use the net proceeds along with its existing cash, cash equivalents, and marketable securities, to support the regulatory, pre-commercial and potential commercial launch activities for LNZ100 as well as for working capital and general corporate purposes.
More on LENZ Therapeutics, Inc.
- LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript
- Historical earnings data for LENZ Therapeutics, Inc.
- Financial information for LENZ Therapeutics, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
